申请人:The Procter and Gamble Company
公开号:US20030162778A1
公开(公告)日:2003-08-28
The compounds have a structure according to the following Formula (I):
1
are effective in treating conditions characterized by excess activity of these enzymes.
这些化合物的结构符合以下公式(I):1,对于治疗其酶活性过高的症状是有效的。